|
1
|
Johnston SRD, Harbeck N, Hegg R, Toi M,
Martin M, Shao ZM, Zhang QY, Martinez Rodriguez JL, Campone M,
Hamilton E, et al: Abemaciclib combined with endocrine therapy for
the adjuvant treatment of HR+, HER2-, node-positive, high-risk,
early breast cancer (monarchE). J Clin Oncol. 38:3987–3998.
2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Goetz MP, Toi M, Campone M, Sohn J,
Paluch-Shimon S, Huober J, Park IH, Trédan O, Chen SC, Manso L, et
al: MONARCH 3: Abemaciclib as initial therapy for advanced breast
cancer. J Clin Oncol. 35:3638–3646. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Johnston S, Martin M, Di Leo A, Im SA,
Awada A, Forrester T, Frenzel M, Hardebeck MC, Cox J, Barriga S, et
al: MONARCH 3 final PFS: A randomized study of abemaciclib as
initial therapy for advanced breast cancer. NPJ Breast Cancer.
17(5)2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Johnston S, O'Shaughnessy J, Martin M,
Huober J, Toi M, Sohn J, André VAM, Martin HR, Hardebeck MC and
Goetz MP: Abemaciclib as initial therapy for advanced breast
cancer: MONARCH 3 updated results in prognostic subgroups. NPJ
Breast Cancer. 7(80)2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Santos C, Oliveira RC, Serra P, Baptista
JP, Sousa E, Casanova P, Pimentel J and Carvalho L: Pathophysiology
of acute fibrinous and organizing pneumonia-Clinical and
morphological spectra. Pathophysiology. 26:213–217. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Zhao X, Cheng Y, Xiong Y and Wang G:
Pulmonary tuberculosis associated acute fibrinous and organizing
pneumonia: A case report and literature review. Clin Respir J.
17:499–506. 2023.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Epler GR and Kelly EM: Systematic review
of postradiotherapy bronchiolitis obliterans organizing pneumonia
in women with breast cancer. Oncologist. 19:1216–1226.
2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Vasiljevic D, Arnold C, Neuman D, Fink K,
Popovscaia M, Kvitsaridze I, Nevinny-Stickel M, Glatzer M, Lukas P
and Seppi T: Occurrence of pneumonitis following radiotherapy of
breast cancer-A prospective study. Strahlenther Onkol. 194:520–532.
2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Eggert MC, Yu NY and Rades D: Radiation
dermatitis and pneumonitis in patients irradiated for breast
cancer. In Vivo. 37:2654–2661. 2023.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Werner EM, Eggert MC, Bohnet S and Rades
D: Prevalence and characteristics of pneumonitis following
irradiation of breast cancer. Anticancer Res. 39:6355–6358.
2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Abdeltawab AA, Ali SA, Mostafa HG and
Hassan MA: Predictive factors increasing the risk of radiation
toxicity in patients with early breast cancer. Asian Pac J Cancer
Prev. 22:145–149. 2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Sato H, Ebi J, Tamaki T, Yukawa A,
Nakajima M, Ohtake T and Suzuki Y: Incidence of organizing
pneumonia after whole-breast radiotherapy for breast cancer, and
risk factor analysis. J Radiat Res. 298–302. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wen G, Tan YT, Lan XW, He ZC, Huang JH,
Shi JT, Lin X and Huang XB: New clinical features and dosimetric
predictor identification for symptomatic radiation pneumonitis
after tangential irradiation in breast cancer patients. J Cancer.
8:3795–3802. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Yu TK, Whitman GJ, Thames HD, Buzdar AU,
Strom EA, Perkins GH, Schechter NR, McNeese MD and Kau SW:
Clinically relevant pneumonitis after sequential paclitaxel-based
chemotherapy and radiotherapy in breast cancer patients. J Natl
Cancer Inst. 96:1676–1681. 2004.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Dörr W, Bertmann S and Herrmann T:
Radiation induced lung reactions in breast cancer therapy:
Modulating factors and consequential effects. Strahlenther Onkol.
181:567–573. 2005.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Jeba J, Isiah R, Subhashini J,
Backianathan S, Thangakunam B and Christopher DJ: Radiation
pneumonitis after conventional radiotherapy for breast cancer: A
prospective study. J Clin Diagn Res. 9:XC01–XC05. 2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zaizen Y, Tachibana Y, Ozasa M, Yamano Y,
Takei R, Kohashi Y, Kataoka K, Saito Y, Tabata K, Okamoto M, et al:
Sensitivity of transbronchial lung cryobiopsy in the diagnosis of
different interstitial lung diseases. Sci Rep.
12(22037)2022.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Ramaswamy A, Homer R, Killam J, Pisani MA,
Murphy TE, Araujo K and Puchalski J: Comparison of transbronchial
and cryobiopsies in evaluation of diffuse parenchymal lung disease.
J Bronchology Interv Pulmonol. 23:14–21. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Mathew N, Joel A, Andrews AG, John AO and
Singh A: CDK 4/6 inhibitor induced lung injury: A case report and
review of literature. Ecancermedicalscience.
15(1245)2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kuza C, Matheos T, Kathman D and Heard SO:
Life after acute fibrinous and organizing pneumonia: A case report
of a patient 30 months after diagnosis and review of the
literature. J Crit Care. 31:255–261. 2016.PubMed/NCBI View Article : Google Scholar
|
